Features

The cost of treating hepatitis C has long been a challenge for insurance and medical providers. (Illustration/Shutterstock)
Illustration/Shutterstock

Saving more hepatitis C patients

USC’s Neeraj Sood suggests a novel policy that leverages competition among drug manufacturers, saving states money and ensuring that more people get treatment.